Cefpodoxime Proxetil + Clavulanic Acid in pharma franchise in Madhya Pradesh

Cefpodoxime Proxetil + Clavulanic Acid in PCD pharma franchise in Kohima

Cefpodoxime Proxetil + Clavulanic Acid in top pharma company in Delhi

Cefpodoxime Proxetil + Clavulanic Acid in pcd pharma supplier in Gwalior

Cefpodoxime Proxetil + Clavulanic Acid in phama franchise company in India
Cefpodoxime Proxetil + Clavulanic Acid in phama distributor in Meerut

Home/Products /cefpodoxime-proxetil-100mg-clavulanic-acid-62-point-5mg-dry-syrup

Flickdox CV 100 Dry Syrup

Composition : Cefpodoxime Proxetil (100mg) + Clavulanic Acid (62.5mg)

Dosage Form : Dry Syrup

Packaging Type : Pet with Water

Packaging : 30 ml

Price : ₹153/-

Flickdox CV 100 Dry Syrup contains Cefpodoxime Proxetil (100mg) and Clavulanic Acid (62.5mg), a potent combination designed to combat bacterial infections in children. Cefpodoxime is a third-generation cephalosporin antibiotic that targets and eliminates bacteria by disrupting their cell wall synthesis. Clavulanic acid acts as a beta-lactamase inhibitor, preventing the bacteria from developing resistance to cefpodoxime. Together, they provide a broader spectrum of action against both Gram-positive and Gram-negative bacteria, making this combination highly effective.

This formulation is especially suitable for pediatric use, as the dry syrup can be easily reconstituted and administered to children who may have difficulty swallowing tablets.

Read More

About the Product

Flickdox CV 100 Dry Syrup contains Cefpodoxime Proxetil (100mg) and Clavulanic Acid (62.5mg), a potent combination designed to combat bacterial infections in children. Cefpodoxime is a third-generation cephalosporin antibiotic that targets and eliminates bacteria by disrupting their cell wall synthesis. Clavulanic acid acts as a beta-lactamase inhibitor, preventing the bacteria from developing resistance to cefpodoxime. Together, they provide a broader spectrum of action against both Gram-positive and Gram-negative bacteria, making this combination highly effective.

This formulation is especially suitable for pediatric use, as the dry syrup can be easily reconstituted and administered to children who may have difficulty swallowing tablets.

Common side effects may include gastrointestinal disturbances, such as diarrhea, nausea, and vomiting. Allergic reactions and skin rashes may also occur. Patients should seek medical attention if they experience severe reactions or persistent symptoms.

Flickdox CV 100 is indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, skin and soft tissue infections, and other infections caused by susceptible organisms.

Consult a healthcare professional before use, especially in cases of a known allergy to penicillin or cephalosporin antibiotics. Discontinue use and seek immediate medical advice if severe allergic reactions occur. Flickdox CV 100 Dry Syrup offers a convenient dosing option for pediatric patients and those who may have difficulty swallowing tablets. Its palatable formulation helps ensure better adherence to prescribed treatment regimens, ultimately contributing to effective management of bacterial infections. Always follow the prescribed dosage and duration to ensure the best outcomes while minimizing the risk of antibiotic resistance.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children. After reconstitution, the syrup should be stored in the refrigerator and used within 7 days.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation